AquaBounty Technologies Inc (AQB)

Over the past six months, several events have impacted AquaBounty Technologies, Inc.'s stock price. The company announced its first-quarter, second-quarter, and third-quarter 2025 financial results. A Current Report (8-K) and a Notice of Exempt Offering of Securities (Form D) were filed. An Initial Statement of Beneficial Ownership (Form 3) was also filed. As of November 27, 2025, AQB stock has shown a 9.02% increase over the last six months, although it experienced a -34.51% fall over the last month and a -3.41% decrease over the last year. The share price declined by 10.21% between November 25, 2024, and November 21, 2025.

Given AquaBounty Technologies, Inc.'s announcement in December 2024 to cease fish farming operations and the subsequent sale of its farms in 2024 and early 2025, the concept of demand seasonality for its products is currently not directly applicable to ongoing production. Historically, the company aimed to meet the demand for salmon in the United States, Canada, and Europe, with potential future expansion into Asian markets where salmon consumption is high. However, with the cessation of production, the company is no longer actively producing and selling its AquAdvantage salmon.

AquaBounty Technologies, Inc. (AQB) is a land-based aquaculture company specializing in biotechnology to enhance fish farming productivity and sustainability. The company operates in the Consumer Staples sector, specifically in the Farm Products industry, and is also categorized under Biotechnology and Aquaculture. AquaBounty's primary product is the AquAdvantage Salmon, a genetically engineered Atlantic salmon designed for faster growth using a gene from a Chinook salmon. The company's land-based recirculating aquaculture systems are designed to prevent disease and protect wild fish populations.

AquaBounty Technologies, Inc. was headquartered in Harvard, Massachusetts, United States. The company previously operated aquaculture facilities in Prince Edward Island, Canada, and Indiana, USA. In 2020, Mayfield, Kentucky, was identified as a potential location for a large-scale farm, and construction began in April 2022 on a significant production facility in Pioneer, Ohio, but construction was paused due to increased costs. As of December 2024, AquaBounty announced plans to cease fish farming operations and has since sold its Canadian and Indiana farms.

AquaBounty Technologies has faced challenges to its brand reputation, particularly in the context of its genetically modified AquAdvantage Salmon, which has been referred to as "Frankenfish" by some. In the past year, the company's reputation has been significantly impacted by a series of critical announcements in late 2024 and early 2025. The decision to cease all salmon-farming operations, including the closure of its Bay Fortune operation and the culling of fish in December 2024, and the subsequent sale of its farms, led to a plummet in stock price and raised questions about the viability of commercial-scale genetically modified food production. This operational halt and leadership change, including the resignation of CEO David Melbourne in December 2024, severely eroded investor confidence and fundamentally altered the company's identity from a GM salmon producer.

AquaBounty Technologies, Inc. is owned by a mix of institutional, insider, and retail investors. Randal J. Kirk is the largest individual shareholder, owning 32.12 million shares, representing 828.34% of the company. Major institutional owners include DRW Securities, LLC, Epiq Partners, Llc, BlackRock, Inc., Two Sigma Investments, Lp, Geode Capital Management, Llc, Vanguard Group Inc, and Renaissance Technologies Llc. Institutional shareholders hold approximately 10.93% of the company's stock, while insiders hold a significant 2,493.66%.